Happy 4th of July!

Happy 4th of July from all of us here at the Psychedelics Law Blog!

We hope you have a fun, safe and not-too-hot holiday with family and friends.

We will be back soon with our regular programming.

Study shows no developmental delays in toddlers post-COVID-19 infection

Study explored the relationship between SARS-CoV-2 infection in children under two years old and cognitive development, finding no evidence of increased developmental delays post-infection. Differences

October 15, 2024

‘Sluggish’ Hospital Uptake of Newer Antibiotics for Gram-Negative Infections

Hospital uptake of newer antibiotics to treat multidrug-resistant gram-negative bacteria was low over a 5-year period, according to a retrospective cohort study. Fully 41.5% of

April 20, 2024

Pα+ Psychedelic Bulletin #162: EQUULUS Therapeutics Emerges from Stealth; Responses to ICER’s Draft Evidence Report on Lykos’ MDMA; and more… – Psychedelic Alpha

Featured content in this Issue: EQUULUS Therapeutics Emerges from Stealth with Non-Hallucinogenic Ibogaine Analog as Lead Candidate Responses to ICER’s Draft Evidence Report on MDMA-Assisted

April 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.